173 related articles for article (PubMed ID: 20082533)
1. Downregulation of miR-21 enhances chemotherapeutic effect of taxol in breast carcinoma cells.
Mei M; Ren Y; Zhou X; Yuan XB; Han L; Wang GX; Jia Z; Pu PY; Kang CS; Yao Z
Technol Cancer Res Treat; 2010 Feb; 9(1):77-86. PubMed ID: 20082533
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-424-5p enhances chemosensitivity of breast cancer cells to Taxol and regulates cell cycle, apoptosis, and proliferation.
Dastmalchi N; Safaralizadeh R; Hosseinpourfeizi MA; Baradaran B; Khojasteh SMB
Mol Biol Rep; 2021 Feb; 48(2):1345-1357. PubMed ID: 33555529
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-16 sensitizes breast cancer cells to paclitaxel through suppression of IKBKB expression.
Tang X; Jin L; Cao P; Cao K; Huang C; Luo Y; Ma J; Shen S; Tan M; Li X; Zhou M
Oncotarget; 2016 Apr; 7(17):23668-83. PubMed ID: 26993770
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-155-5p promotes tumor progression and contributes to paclitaxel resistance via TP53INP1 in human breast cancer.
Li Y; Zhang L; Dong Z; Xu H; Yan L; Wang W; Yang Q; Chen C
Pathol Res Pract; 2021 Apr; 220():153405. PubMed ID: 33756128
[TBL] [Abstract][Full Text] [Related]
5. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Qiu Y; Yagüe E; Ji W; Liu J; Zhang J
Cell Death Dis; 2016 Jun; 7(6):e2291. PubMed ID: 27362808
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol.
Ren Y; Zhou X; Mei M; Yuan XB; Han L; Wang GX; Jia ZF; Xu P; Pu PY; Kang CS
BMC Cancer; 2010 Jan; 10():27. PubMed ID: 20113523
[TBL] [Abstract][Full Text] [Related]
7. Anti-miR-155 oligonucleotide enhances chemosensitivity of U251 cell to taxol by inducing apoptosis.
Meng W; Jiang L; Lu L; Hu H; Yu H; Ding D; Xiao K; Zheng W; Guo H; Ma W
Cell Biol Int; 2012 Jul; 36(7):653-9. PubMed ID: 22276743
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression.
Zhou M; Liu Z; Zhao Y; Ding Y; Liu H; Xi Y; Xiong W; Li G; Lu J; Fodstad O; Riker AI; Tan M
J Biol Chem; 2010 Jul; 285(28):21496-507. PubMed ID: 20460378
[TBL] [Abstract][Full Text] [Related]
9. The combined therapy of miR-383-5p restoration and paclitaxel for treating MDA-MB-231 breast cancer.
Dastmalchi N; Azarbarzin S; Safaralizadeh R; Khojasteh SMB; Shadbad MA; Amini M; Baghbanzadeh A; Asl ER; Baghbani E; Lotfinejad P; Baradaran B
Med Oncol; 2021 Nov; 39(1):9. PubMed ID: 34761351
[TBL] [Abstract][Full Text] [Related]
10. LncRNA HOTAIR contributes Taxol-resistance of hepatocellular carcinoma cells via activating AKT phosphorylation by down-regulating miR-34a.
Duan Y; Chen J; Yang Y; Qu Z; Lu Y; Sun D
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32700738
[TBL] [Abstract][Full Text] [Related]
11. miR-339-5p downregulation contributes to Taxol resistance in small-cell lung cancer by targeting α1,2-fucosyltransferase 1.
Gan CZ; Li G; Luo QS; Li HM
IUBMB Life; 2017 Nov; 69(11):841-849. PubMed ID: 28940895
[TBL] [Abstract][Full Text] [Related]
12. miR-27b-3p inhibits proliferation and potentially reverses multi-chemoresistance by targeting CBLB/GRB2 in breast cancer cells.
Chen D; Si W; Shen J; Du C; Lou W; Bao C; Zheng H; Pan J; Zhong G; Xu L; Fu P; Fan W
Cell Death Dis; 2018 Feb; 9(2):188. PubMed ID: 29416005
[TBL] [Abstract][Full Text] [Related]
13. Differential altered expression of let-7a and miR-205 tumor-suppressor miRNAs in different subtypes of breast cancer under treatment with Taxol.
Asghari F; Haghnavaz N; Shanehbandi D; Khaze V; Baradaran B; Kazemi T
Adv Clin Exp Med; 2018 Jul; 27(7):941-945. PubMed ID: 30019863
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of c-FLIP expression by miR-512-3p contributes to taxol-induced apoptosis in hepatocellular carcinoma cells.
Chen F; Zhu HH; Zhou LF; Wu SS; Wang J; Chen Z
Oncol Rep; 2010 May; 23(5):1457-62. PubMed ID: 20372864
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of miR-203 sensitizes paclitaxel (Taxol)-resistant colorectal cancer cells through targeting the salt-inducible kinase 2 (SIK2).
Liu Y; Gao S; Chen X; Liu M; Mao C; Fang X
Tumour Biol; 2016 Sep; 37(9):12231-12239. PubMed ID: 27236538
[TBL] [Abstract][Full Text] [Related]
16. Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer.
Chen X; Wang YW; Xing AY; Xiang S; Shi DB; Liu L; Li YX; Gao P
J Pathol; 2016 Aug; 239(4):459-72. PubMed ID: 27171498
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-193a and taxol combination: A new strategy for treatment of colorectal cancer.
Hejazi M; Baghbani E; Amini M; Rezaei T; Aghanejad A; Mosafer J; Mokhtarzadeh A; Baradaran B
J Cell Biochem; 2020 Feb; 121(2):1388-1399. PubMed ID: 31512793
[TBL] [Abstract][Full Text] [Related]
18. MiR-1204 sensitizes nasopharyngeal carcinoma cells to paclitaxel both in vitro and in vivo.
Peng X; Cao P; Li J; He D; Han S; Zhou J; Tan G; Li W; Yu F; Yu J; Li Z; Cao K
Cancer Biol Ther; 2015; 16(2):261-7. PubMed ID: 25756509
[TBL] [Abstract][Full Text] [Related]
19. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Xu K; Yagüe E
Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
[TBL] [Abstract][Full Text] [Related]
20. HOXB4 knockdown enhances the cytotoxic effect of paclitaxel and cisplatin by downregulating ABC transporters in ovarian cancer cells.
Li Y; Sun J; Gao S; Hu H; Xie P
Gene; 2018 Jul; 663():9-16. PubMed ID: 29660518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
